首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1904816

血液學診斷市場規模、佔有率和成長分析（按產品、檢測、最終用戶和地區分類）—2026-2033年產業預測

Hematology Diagnostics Market Size, Share, and Growth Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，血液診斷市場規模將達到 67.5 億美元，到 2025 年將達到 71.1 億美元，到 2033 年將達到 106.6 億美元，預測期（2026-2033 年）的複合年成長率為 5.2%。

血液學診斷市場的根本目標是提升醫療專業人員的診斷準確率，從而實現適當的治療並改善患者照護。該領域的成長主要受血液疾病發病率上升以及對早期檢測和精準診斷需求不斷成長的推動。自動化血液分析儀和就地檢驗設備等技術進步實現了快速且高效的血液分析，為市場擴張提供了巨大的機會。儘管成本和對專業技術人員的需求等挑戰依然存在，但創新和個人化醫療的興起正在為市場的進一步成長鋪平道路。隨著醫學界逐漸認知到血液學診斷在改善患者預後和實現標靶治療的重要作用，預計該市場將繼續擴張。

血液診斷市場成長要素

貧血、白血病和血友病等血液疾病發生率的不斷上升，正顯著推動血液學診斷市場的成長。隨著醫療服務提供者和患者都高度重視這些疾病的準確快速診斷，創新血液學診斷工具和技術的應用也隨之激增。人們對有效診斷解決方案日益成長的認知和需求，正在推動該領域的研究和開發，最終改善患者照護和治療效果。對早期檢測的重視，進一步凸顯了血液學診斷在血液疾病管理中的關鍵作用。

血液學診斷市場限制因素

血液學診斷設備和試劑的高昂成本對市場成長構成重大挑戰。購買這些先進技術的初始投資以及持續的維護成本可能會阻礙血液學診斷解決方案的廣泛應用。在資源有限的醫療機構中，預算限制可能會使這些機構不願意投資這些必要的工具，這種情況尤其明顯。因此，高昂的經濟門檻可能會限制人們獲得先進的診斷能力，最終影響整個血液學診斷市場的發展和擴張。

血液學診斷市場趨勢

血液學診斷市場正經歷著就地檢驗（POCT）的重大轉變，其驅動力在於對快速且高效診斷的需求，以增強臨床決策。這一趨勢的特點是攜帶式和手持式血液分析儀的推出，使醫護人員能夠直接在患者身邊或基層醫療機構進行檢測。這些創新不僅加快了診斷流程，而且透過實現及時干預，有助於改善患者預後。隨著醫療產業越來越重視便利性和可及性，照護現場技術的應用有望改變血液學診斷格局，並促進更個人化和響應迅速的患者照護。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Sysmex Corporation（Japan）
Danaher Corporation（USA）
Abbott Laboratories（USA）
Siemens Healthineers（Germany）
Mindray（China）
Bio-Rad Laboratories（USA）
Nihon Kohden（Japan）
Boule Diagnostics（Sweden）
EKF Diagnostics（UK）
Horiba（Japan）
Roche Diagnostics（Switzerland）
Beckman Coulter（USA）
Diatron（Hungary）
Erba Mannheim（Germany）
Ortho Clinical Diagnostics（US）
Cellavision（Sweden）
Drucker Diagnostics（USA）
Heska Corporation（USA）
Neomedica（Germany）
Thermo Fisher Scientific（USA）

結論與建議

簡介目錄

Product Code: SQMIG35B2185

Hematology Diagnostics Market size was valued at USD 6.75 Billion in 2024 and is poised to grow from USD 7.11 Billion in 2025 to USD 10.66 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The hematology diagnostics market is fundamentally geared towards enhancing healthcare professionals' ability to deliver accurate diagnoses, facilitating appropriate treatment and improved patient care. Growth in this sector is propelled by the rising incidence of blood disorders and an increasing demand for early detection and precise diagnostics. Technological advancements, including automated hematology analyzers and point-of-care testing devices, are catalyzing rapid and efficient blood analysis, presenting significant opportunities for market expansion. While challenges such as cost and the need for skilled personnel persist, innovations and the rise of personalized medicine are paving the way for further growth. The market is likely to broaden as the healthcare community acknowledges the critical role of hematology diagnostics in elevating patient outcomes and enabling targeted therapeutic approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hematology Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hematology Diagnostics Market Segments Analysis

Global Hematology Diagnostics Market is segmented by product, test, end user and region. Based on product, the market is segmented into instrument and consumables. Based on test, the market is segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood count and others. Based on end user, the market is segmented into hospitals, diagnostics labs and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Hematology Diagnostics Market

The rise in the occurrence of blood-related disorders, including conditions like anemia, leukemia, and hemophilia, significantly fuels the growth of the hematology diagnostics market. As healthcare providers and patients alike prioritize the need for precise and timely diagnosis of these ailments, there is a corresponding surge in the adoption of innovative hematology diagnostic tools and technologies. This heightened awareness and demand for effective diagnostic solutions are pushing the boundaries of research and development in the field, ultimately enhancing patient care and treatment outcomes. The focus on early detection further emphasizes the essential role that hematology diagnostics play in managing blood disorders.

Restraints in the Hematology Diagnostics Market

The substantial expenses linked to hematology diagnostic instruments and reagents pose a significant challenge to the growth of the market. The initial capital required for purchasing these advanced technologies, along with ongoing maintenance costs, can hinder the widespread adoption of hematology diagnostic solutions. This is especially pertinent in healthcare environments with limited resources, where budget constraints may prevent facilities from investing in these essential tools. As a result, the high financial barrier may restrict access to advanced diagnostic capabilities, ultimately affecting the overall development and expansion of the hematology diagnostics market.

Market Trends of the Hematology Diagnostics Market

The Hematology Diagnostics market is witnessing a significant shift towards point-of-care testing, driven by the demand for rapid and efficient diagnosis that enhances clinical decision-making. This trend is characterized by the introduction of portable and handheld hematology analyzers that allow healthcare professionals to perform tests directly at the patient's side or in primary care environments. Such innovations not only expedite the diagnostic process but also contribute to improved patient outcomes by enabling timely intervention. As the healthcare industry increasingly prioritizes convenience and accessibility, the adoption of point-of-care technologies is expected to reshape the landscape of hematology diagnostics, promoting more personalized and responsive patient care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Hematology Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Instrument
- Analyzer
- Flow Cytometers
Consumables
- Reagents
- Stains
- Others

Global Hematology Diagnostics Market Size by Test & CAGR (2026-2033)

Market Overview
Anemia
Hemoglobinopathy
Leukemia/Lymphoma Phenotyping
Hematology Pathophysiology
Complete Blood Count
Others

Global Hematology Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostics Labs
Others

Global Hematology Diagnostics Market Size & CAGR (2026-2033)

North America (Product, Test, End User)
- US
- Canada
Europe (Product, Test, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Test, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Test, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Test, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diatron (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Erba Mannheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellavision (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Drucker Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neomedica (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments